The clinical presentation of restenosis after bare metal stent implantation: behind a facade of benignity.
Contrary to common belief, bare metal in-stent restenosis (ISR) seems to be not a benign clinical entity. Thus,we believed that continued efforts are warranted to prevent bare metal ISR, including aggressive use of drug-eluting stent (DES) to decrease the incidence of acute coronary syndromes. However, despite improved outcomes with DES, bare metal stent (BMS) will continue to play a role for both clinical and economic reasons and we feel that there is still a future for BMS.
Celik
Turgay
T
Iyisoy
Atila
A
Yuksel
Cagdas
C
Jata
Bekim
B
Isik
Ersoy
E
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D023903:Coronary Restenosis / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome